In episode 4 of Ai Meets Life Sci, Kayleen Brown, managing editor at DeviceTalks and Brian Buntz, pharma and biotech editor, chat with Helen Merianos, Ph.D., head of R+D portfolio strategy at Sanofi and Michelle Longmire, MD, CEO of Medable. The focus? The two-fold application of AI in their respective companies’ technologies, both for scientific advancement…
Medable and CVS Health partner to expand clinical trial access
Medable and CVS Health (NYSE:CVS) announced yesterday that they will collaborate to expand clinical trial access and engagement. Under the collaboration, Medable’s software platform will be combined with CVS Health’s community reach and experienced MinuteClinic providers to deliver clinical trials in a manner that improves patient access, engagement and retention. According to a news release,…
Decentralized clinical trials can have big financial upside, study finds
The use of decentralized clinical trials (DCTs) exploded during the pandemic, but quantifying their financial benefits has been elusive. Medable (Palo Alto, California), the maker of a cloud-based DCT platform, has announced that DCTs can accelerate clinical trial timelines and lead to significant cost savings. Medable and its research partner, the Tufts Center for the Study…
Medable’s CSO opens up on rethinking clinical drug development
Direct-to-patient clinical trial company Medable (Palo Alto, California) has recently hired MaryAnne Rizk as its chief strategy officer. Rizk was IQVIA’s former senior vice president, digital R&D strategy. Rizk was also recently named a PharmaVoice 100 leader. Rizk is also a graduate advisor and an adjunct professor for the school of engineering at the Stevens Institute of…
Medable installs new chief strategy officer
Direct-to-patient clinical trial company Medable (Palo Alto, California) has added MaryAnne Rizk to its executive team. Rizk formerly worked at IQVIA as a senior vice president, digital R&D strategy. She is also an adjunct professor at the Steven Institute of Technology (Hoboken, New Jersey) and a managing partner at Rizk Management Consulting. In August, Rizk…
The top digital health startups in the world
CB Insights’ second annual Digital Health 150 list includes 26 startups seeking to improve drug research and development, an area hard-hit as the COVID-19 pandemic interrupts clinical trials. Drug discovery companies include Healx (rare diseases) and ProteinQure (quantum computing). (Download the full report here.) Get the full story on our sister site Medical Design & Outsourcing. …